Understanding the Challenging Reality of IBS-C for Patients
Recent findings from Ardelyx, Inc. highlight the significant impact irritable bowel syndrome with constipation (IBS-C) has on patients' everyday lives. As part of the IBS in America 2024 supplemental survey, results were showcased at a prominent medical gathering. The survey aimed to delve into the experiences of over 280 affected individuals and the profound effect IBS-C has on their physical and mental well-being.
The Profound Effects on Quality of Life
Survey results revealed that an alarming 90% of respondents reported experiencing either "some" or "significant" negative influence of IBS-C in their lives. Johannah Ruddy, director of patient advocacy at Ardelyx, emphasized that the repercussions extend beyond mere symptoms of constipation, significantly lowering their quality of life.
Insights into Daily Struggles
Patients expressed concerns that IBS-C affected various aspects of their lives, including mental and emotional health, intimacy, and personal relationships. Many participants described their quality of life as "poor" or "fair," which is often compounded by additional health issues such as chronic pain and mental health disorders.
Addressing Common Symptoms
Additional findings from the survey shed light on common symptoms experienced by patients. For instance, 85% reported feeling pain during bowel movements, while over 55% indicated experiencing a sensation of incomplete bowel movements frequently. Other prevalent symptoms included bloating (86%), abdominal cramps (85%), and fatigue (64%).
Understanding Comorbidities and Their Impacts
Many patients reported suffering from various comorbid conditions that add to the burden of IBS-C. This may include chronic pain issues, metabolic disorders, and other gastrointestinal ailments. Notably, more than one-third of those surveyed attributed their struggles with IBS-C to multiple health conditions that exacerbate their discomfort.
The Influence of Menstruation
Among those surveyed who were perimenopausal or menstruating, more than 45% felt that menstruation magnified their constipation struggles, with over 80% indicating it worsened abdominal pain and bloating. This highlights the need to understand how different life stages can affect the management of IBS-C.
Financial Hardships Associated with IBS-C
The survey also uncovered that 45% of participants viewed IBS-C as a substantial financial burden. The costs associated with managing both the symptoms and the general impact of the condition can affect both patients and their families significantly, making it essential for healthcare providers to acknowledge and address these financial implications in treatment discussions.
Broader Implications for Health Conversations
This pivotal survey serves as a call to action for increased awareness and dialogue surrounding IBS-C. The insights gathered aim to foster productive discussions between IBS-C sufferers and their healthcare providers. Ardelyx intends to use these findings to influence approaches towards treatment, aiming for improved strategies to alleviate the challenges that come with this condition.
About IBS-C and Ardelyx
Irritable bowel syndrome with constipation, affecting an estimated 12 million individuals in the U.S., remains a significant yet often misunderstood disorder. Ardelyx, Inc. is at the forefront of developing innovative treatments for IBS-C, including their approved products: IBSRELA and XPHOZAH. The company is committed to improving the lives of patients facing such challenging health conditions by striving for better healthcare outcomes.
Frequently Asked Questions
What is IBS-C?
IBS-C stands for Irritable Bowel Syndrome with Constipation, a common disorder affecting bowel function and causing abdominal discomfort.
How does IBS-C impact daily life?
IBS-C can significantly affect various aspects of a patient’s life, including mental health, relationships, and overall quality of life.
What are the common symptoms of IBS-C?
Common symptoms include constipation, bloating, abdominal pain, and sensations of incomplete bowel movements.
What did the Ardelyx survey reveal?
The survey highlighted that 90% of respondents reported significant negative impacts on their daily lives due to IBS-C symptoms.
How can patients manage IBS-C?
Management strategies may include dietary changes, medication, and establishing effective communication with healthcare providers about symptom management.
